Multiple sclerosis, or MS, casts a shadow over the lives of millions worldwide, its complexities challenging both patients and researchers. Stemming from autoimmune assaults on the nervous system, recent strides in research have illuminated a potential diagnostic signature years before a clinical presentation.
